(9-016) Evaluation of Safety and Efficacy Outcomes for Patients with Carbapenem-Resistant Pseudomonas aeruginosa Infections Treated with Cefepime or Piperacillin-Tazobactam in a Large Community Hospital
Wednesday, December 10, 2025
8:30 AM - 9:30 AM
Location: Bayside A, Level 1
Residency Program: Huntsville Hospital Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Alabama